Clinical trial

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

NCT02621489

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhasePHASE4

Study timeline

Study start (unknown)2015-12-01Date precision: month

Registry last updated2023-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atherosclerosisunresolved

Diabetesunresolved

Restenosisunresolved

Interventions

BydureonDRUG · verified · RxNorm: Bydureon

Humulin kwickpenDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Karolinska Institutetlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02621489 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.